Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Dhanvantri Jeevan Rekha Ltd

Your Vote -

Buy

20.00%

Hold

40.00%

Sell

40.00%

20.00%

5 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dhanvantri Jeevan Rekha Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dhanvantri Jeeva - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    14 Feb 2025, 6:43PM Scrutinizer Report
  • Dhanvantri Jeeva - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    14 Feb 2025, 6:40PM Outcome of the postal ballot
  • Dhanvantri Jeeva Q3 net profit down 58.33% at Rs 0.15 cr

    13 Feb 2025, 5:10PM The company reported standalone net profit of Rs 0.15 crore for the quarter ended December 31, 2024 as compared to Rs 0.36 crore in the same period la
  • Dhanvantri Jeeva - Integrated Filing (Financial)

    13 Feb 2025, 3:52PM Financial
  • Dhanvantri Jeeva - Result Financial Result Dec 2024

    13 Feb 2025, 3:48PM Result for the quarter Dec 2024
  • Dhanvantri Jeeva - Board Meeting Outcome for Quarterly Result For Dec2024

    13 Feb 2025, 3:41PM Quarterly Result for Dec 2024
  • Dhanvantri Jeeva - Board Meeting Intimation for The Board Meeting Intimation For The Board Meeting To Be Held On 13Th Feb 202

    5 Feb 2025, 4:45PM DHANVANTRI JEEVAN REKHA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to cons
  • Dhanvantri Jeeva has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    21 Jan 2025, 9:00AM As of December 2024, 19.65% is owned by Indian Promoters and 80.35% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Dhanvantri Jeeva - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    17 Jan 2025, 9:51AM The compliance certificate under 74(5)
  • Dhanvantri Jeeva - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    14 Jan 2025, 4:57AM The company is in the process of seeking approval of the shareholders as set out in the postal ballot notice dated Jan 13th 2025 special resolution. \
  • Dhanvantri Jeeva - Board Meeting Outcome for Outcome Of The Board Meeting Held On 06TH January 2025 Pursuant To Regulation 30

    6 Jan 2025, 4:08PM 1.Considered the passing of resolutions by postal ballot to obtain Shareholder's approval for the ratification of the appointment of Mr. Ravi Karan (D
  • Dhanvantri Jeeva - Board Meeting Intimation for The Board Meeting Is Schedule On 6Th January 2025

    28 Dec 2024, 6:11PM DHANVANTRI JEEVAN REKHA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/01/2025 ,inter alia, to cons

Key fundamentals

Evaluate the intrinsic value of Dhanvantri Jeevan Rekha Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 9.4737 9.3085 9.5251 9.1061 10.5592
Liabilities 9.4737 9.3085 9.5251 9.1061 10.5592
Equity 4.1536 4.1536 4.1536 4.1536 4.1536
Gross Profit 0.8339 0.58 1.4921 -0.7492 0.6649
Net Profit 0.1652 -0.2166 0.4901 -1.4233 -0.2642
Cash From Operating Activities 2.5162 -39.02 0.001 -0.3488 1.3794
NPM(%) 0.8 -1.22 2.92 -14.55 -1.45
Revenue 20.4619 17.6848 16.7715 9.7823 18.2071
Expenses 19.628 17.1048 15.2793 10.5315 17.5422
ROE(%) 1.75 -2.3 5.2 -15.11 -2.8

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dhanvantri Jeevan Rekha Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 809.25 -0.64 11.41 9.71 1321.50 1.42
Lotus Eye Hospital and Institute Ltd 58.19 1.50 237.75 35.37 14.01 0.88
Bharat Immunological and Biologicals Corporation Ltd 21.32 -1.30 0.00 73.45 -39.50 0.00
Astec Lifesciences Ltd 654.90 -5.39 0.00 33.36 -239.30 0.00

Company Info

The Company was incorporated on 11th day of June, 1993 as a Public Limited Company with the Registrar of Companies in Utter Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI). The company obtained certificate for commencement of business on 2nd August 1993. The Company was incorporated with an authorised capital of Rs. 200.00 lacs which was subsequentiy increased to Rs. 500.00 Lacs from time to time. In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagonostic equipments in the Urology and Cardiology sections have already been installed and are in operation. The first case of Therapeutic services un urology section has been successfully performed on 10/ 01/95. 2002 -The Company appointed Mr Virendra Singh Phull as Managing Director. 2008 -The Company has recommend dividend of 4% on the equity. 2011 -The Company has recommended final dividend of 4% (equivalent to Rs. 0.40) per Equity share (face value Rs. 10/- each ).

The Company was incorporated on 11th day of June, 1993 as a Public Limited Company with the Registrar of Companies in Utter Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI). The company obtained certificate for commencement of business on 2nd August 1993. The Company was incorporated with an authorised capital of Rs. 200.00 lacs which was subsequentiy increased to Rs. 500.00 Lacs from time to time. In the month of October 1993 the company acquired a constructed building at 1, Saket, Meerut for establishing the Diagnostic Centre. The renovation of the site has already been completed. Diagonostic equipments in the Urology and Cardiology sections have already been installed and are in operation. The first case of Therapeutic services un urology section has been successfully performed on 10/ 01/95. 2002 -The Company appointed Mr Virendra Singh Phull as Managing Director. 2008 -The Company has recommend dividend of 4% on the equity. 2011 -The Company has recommended final dividend of 4% (equivalent to Rs. 0.40) per Equity share (face value Rs. 10/- each ).

Read More

Parent Organisation

Dhanvantri Jeevan Rekha Ltd.

Founded

11/06/1993

Managing Director

Mrs.Shalini Sharma

NSE Symbol

FAQ

The current price of Dhanvantri Jeevan Rekha Ltd is

The 52-week high for Dhanvantri Jeevan Rekha Ltd is

The market capitalization of Dhanvantri Jeevan Rekha Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dhanvantri Jeevan Rekha Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dhanvantri Jeevan Rekha Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dhanvantri Jeevan Rekha Ltd shares.

The CEO of Dhanvantri Jeevan Rekha Ltd is Mrs.Shalini Sharma, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT